ABILIFY MAINTENA Depot susp inj 400 mg 1 PFS
7680657740011
CH-65774
N05AX12
01.05.0.
Active substances:
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6577401
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- Praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, ad pulverem. Solvens: aqua ad iniectabile. Solutio reconstituta: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 2.2 mg.
Articles (1)
Abilify Maintena 400 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
aripiprazolum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
aripiprazolum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
aripiprazolum monohydricum
|
- | Substance | WIZUS |
|
aripiprazolum monohydricum
|
- | Substance | WIZUS |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 311.95
Specialties list
Yes
Generic
No
SL addition date:
01/05/2016
Authorization holder
Lundbeck (Schweiz) AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 65774
- Drug name
- Abilify Maintena, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
- Galenic form
- PULMR
- ATC Code
- N05AX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/03/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ABILIFY MAINTENA Depot susp inj 400 mg 1 PFS
- Description (DE)
- ABILIFY MAINTENA Depot Inj Susp 400 mg 1 PFS
- Market launch
- 15/03/2016
- Narcotic (BTM)
- No